125 related articles for article (PubMed ID: 27789944)
1. Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma.
Will OM; Purcz N; Chalaris A; Heneweer C; Boretius S; Purcz L; Nikkola L; Ashammakhi N; Kalthoff H; Glüer CC; Wiltfang J; Açil Y; Tiwari S
Int J Nanomedicine; 2016; 11():5311-5321. PubMed ID: 27789944
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of electrospun poly(D,L lactide-co-glycolide)80/20 scaffolds loaded with diclofenac sodium for tissue engineering.
Nikkola L; Morton T; Balmayor ER; Jukola H; Harlin A; Redl H; van Griensven M; Ashammakhi N
Eur J Med Res; 2015 Jun; 20(1):54. PubMed ID: 26044589
[TBL] [Abstract][Full Text] [Related]
3. Investigation of localized delivery of diclofenac sodium from poly(D,L-lactic acid-co-glycolic acid)/poly(ethylene glycol) scaffolds using an in vitro osteoblast inflammation model.
Sidney LE; Heathman TR; Britchford ER; Abed A; Rahman CV; Buttery LD
Tissue Eng Part A; 2015 Jan; 21(1-2):362-73. PubMed ID: 25104438
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Lactidyl/Glycolidyl Ratio and Molecular Weight of Poly(D,L -Lactide-co-Glycolide) on the Tetracycline Entrapment and Release Kinetics of Drug-Loaded Nanofibers.
Yan N; Zhang X; Cai Q; Yang X; Zhou X; Wang B; Deng X
J Biomater Sci Polym Ed; 2012; 23(8):1005-19. PubMed ID: 21477461
[TBL] [Abstract][Full Text] [Related]
5. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
[TBL] [Abstract][Full Text] [Related]
6. Effects of 10-hydroxycamptothecin, delivered from locally injectable poly(lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model.
Mallery SR; Shenderova A; Pei P; Begum S; Ciminieri JR; Wilson RF; Casto BC; Schuller DE; Morse MA
Anticancer Res; 2001; 21(3B):1713-22. PubMed ID: 11497251
[TBL] [Abstract][Full Text] [Related]
7. In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.
Nieto K; Pei P; Wang D; Mallery SR; Schwendeman SP
Int J Pharm; 2018 Mar; 538(1-2):48-56. PubMed ID: 29170116
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
Ferdous T; Harada K; Kin T; Harada T; Ueyama Y
Int J Oncol; 2013 Jul; 43(1):271-9. PubMed ID: 23695365
[TBL] [Abstract][Full Text] [Related]
9. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
10. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
11. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
12. The effect of single agent oral fusaric acid (FA) on the growth of subcutaneously xenografted SCC-1 cells in a nude mouse model.
Ruda JM; Beus KS; Hollenbeak CS; Wilson RP; Stack BC
Invest New Drugs; 2006 Sep; 24(5):377-81. PubMed ID: 16505952
[TBL] [Abstract][Full Text] [Related]
13. Metformin Effects on Metabolic Coupling and Tumor Growth in Oral Cavity Squamous Cell Carcinoma Coinjection Xenografts.
Tassone P; Domingo-Vidal M; Whitaker-Menezes D; Lin Z; Roche M; Tuluc M; Martinez-Outschoorn U; Curry J
Otolaryngol Head Neck Surg; 2018 May; 158(5):867-877. PubMed ID: 29232177
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
Nystrom ML; McCulloch D; Weinreb PH; Violette SM; Speight PM; Marshall JF; Hart IR; Thomas GJ
Cancer Res; 2006 Nov; 66(22):10833-42. PubMed ID: 17108119
[TBL] [Abstract][Full Text] [Related]
15. (-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo.
Wolter KG; Wang SJ; Henson BS; Wang S; Griffith KA; Kumar B; Chen J; Carey TE; Bradford CR; D'Silva NJ
Neoplasia; 2006 Mar; 8(3):163-72. PubMed ID: 16611409
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
[TBL] [Abstract][Full Text] [Related]
17. The drug efficacy and adverse reactions in a mouse model of oral squamous cell carcinoma treated with oxaliplatin at different time points during a day.
Yang K; Zhao N; Zhao D; Chen D; Li Y
Drug Des Devel Ther; 2013; 7():511-7. PubMed ID: 23818762
[TBL] [Abstract][Full Text] [Related]
18. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
19. The RAG 2 mouse model for xenografted human oral squamous cell carcinoma.
Reuther T; Kübler AC; Staff CJ; Flechtenmacher C; Haase T; Zillmann U
Contemp Top Lab Anim Sci; 2002 Mar; 41(2):31-5. PubMed ID: 11958601
[TBL] [Abstract][Full Text] [Related]
20. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
